バイオ外科手術用製品の世界市場：外科用接着剤、止血薬、軟部組織パッチ、合成メッシュ、癒着防止材料、移植骨代用材...市場調査レポートについてご紹介

1 Introduction (Page No. – 12)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 16)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primary Interviews
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 24)

4 Premium Insights (Page No. – 27)
4.1 Growth Potential for the Market of Biosurgery
4.2 Asia-Pacific: Biosurgery Market, By Product (2014)
4.3 Biosurgery Market: Geographic Growth Opportunities
4.4 Biosurgery Market, Regional Mix
4.5 Biosurgery Market: Developed vs Developing Countries

5 Market Overview (Page No. – 31)
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Type
5.2.2 By Application
5.3 Market Dynamics
5.4 Market Drivers
5.4.1 Rising Number of Surgeries
5.4.2 Increasing Incidence of Sports-Related Injuries and Spinal Problems
5.4.3 Rapid Rise in Aging Population
5.5 Market Restraints
5.5.1 Little-To-No Reimbursements for Biosurgery
5.6 Market Opportunities
5.6.1 Improving Healthcare Systems in Emerging Markets With Growing Public & Private Investments
5.7 Market Challenges
5.7.1 High Price of Biosurgery & Rising Cost of Surgical Procedures

6 Industry Insights (Page No. – 40)
6.1 Introduction
6.2 Industry Trends
6.2.1 Growing Preference for Biological Meshes in Surgerical Procedures
6.2.2 Increasing Acquisitions in Biosurgery Market Leads to Consolidation in the Market
6.3 Porter’s Five Forces Analysis
6.3.1 Threat From New Entrants
6.3.2 Threat From New Substitutes
6.3.3 Bargaining Power of Suppliers
6.3.4 Bargaining Power of Buyers
6.3.5 Intensity of Competitive Rivalry
6.4 Strategic Benchmarking
6.4.1 Product Portfolio Analysis: Biosurgery Market

7 Biosurgery Market, By Product (Page No. – 48)
7.1 Introduction
7.2 Surgical Sealants
7.2.1 Fibrin Sealants
7.2.2 Synthetic Agents/Cyanoacrylates
7.2.3 Collagen-Based Sealants
7.2.4 Tissue Adhesive Glues
7.3 Hemostatic Agents
7.4 Adhesion Barriers
7.5 Soft-Tissue Attachments (Soft Tissue Patch/Mesh)
7.5.1 Synthetic Mesh
7.5.2 Biological Mesh
7.5.2.1 Allografts
7.5.2.2 Xenografts
7.6 Bone Graft Subsitutes
7.6.1 Bone Allografts
7.6.2 Demineralized Bone Matrix (DBM)
7.6.3 Bone Morphogenetic Proteins (BMP)
7.6.4 Synthetic Bone Grafts
7.7 Staple Line Reinforcement Agents

8 Biosurgery Market, By Application Key Findings (Page No. – 62)
8.1 Introduction
8.2 Neurological Surgeries
8.3 Cardiovascular Surgeries
8.4 General Surgeries
8.5 Orthopedic Surgeries
8.6 Thoracic Surgeries
8.7 Gynecology Surgeries
8.8 Urology Surgeries
8.9 Reconstructive Surgeries

9 Biosurgery Market, By Geography Key Findings (Page No. – 70)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe (RoE)
9.4 Asia-Pacific (APAC)
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia-Pacific (ROAPAC)
9.5 Rest of the World (RoW)
9.5.1 Latin America
9.5.2 Middle East and Africa

10 Competitive Landscape (Page No. – 90)
10.1 Overview
10.2 Market Share of Biosurgery
10.2.1 Sealants, Hemostatic Agents, Adhesion Barriers, and Staple-Line Reinforcement Agents
10.2.2 Bone-Graft Substitutes
10.2.3 Soft-Tissue Attachments (Tissue Patch/Mesh)
10.3 Competitive Situation and Trends
10.3.1 Mergers and Acquisitions
10.3.2 Others
10.3.3 Expansions
10.3.4 New Product Launches
10.3.5 Agreements, Partnerships, and Alliances

11 Company Profiles (Page No. – 103)
11.1 Introduction
11.2 Baxter International Inc.
11.2.1 Business Overview
11.2.2 Product Offerings
11.2.3 Recent Developments
11.2.4 SWOT Analysis
11.2.5 MnM View
11.3 Johnson & Johnson
11.3.1 Business Overview
11.3.2 Product Offerings
11.3.3 Recent Developments
11.3.4 SWOT Analysis
11.3.5 MnM View
11.4 C.R. BARD, Inc.
11.4.1 Business Overview
11.4.2 Products & Services
11.4.3 Recent Developments
11.4.4 SWOT Analysis
11.4.5 MnM View
11.5 Covidien PLC.
11.5.1 Business Overview
11.5.2 Product Offerings
11.5.3 Recent Developments
11.5.4 SWOT Analysis
11.5.5 MnM View
11.6 Sanofi Group
11.6.1 Business Overview
11.6.2 Product Offerings
11.6.3 Recent Developments
11.6.4 SWOT Analysis
11.6.5 MnM View
11.7 B. Braun Melsungen AG
11.7.1 Business Overview
11.7.2 Product Offerings
11.7.3 Recent Developments
11.8 Atrium Medical Corporation (A Part of Getinge Group)
11.8.1 Business Overview
11.8.2 Product Offerings
11.8.3 Recent Developments
11.9 Cryolife, Inc.
11.9.1 Business Overview
11.9.2 Product Offerings
11.9.3 Recent Developments
11.10 Hemostasis, LLC
11.10.1 Business Overview
11.10.2 Product Offerings
11.11 Stryker Corporation
11.11.1 Business Overview
11.11.2 Product Offerings
11.11.3 Recent Developments

12 Appendix (Page No. – 129)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Introducing Rt: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports

*Details on Key Financials and Growth Strategy Might Not Be Captured in Case of Unlisted Companies.